临床与实验病理学杂志2017，Vol.33Issue(4)：375-378,4.DOI:10.13315/j.cnki.cjcep.2017.04.005
非小细胞肺癌中BRAF V600、EGFR基因突变与临床病理特征的关系
Relationship between the status of BRAF V600 and EGFR gene mutation and clinicopathological features in patients with non-small cell lung cancer
摘要
Abstract
Purpose To study the status of BRAF V600 and EGFR mutations in patients with non-small cell lung cancer (NSCLC) and to examine the relations between them.Methods BRAF V600 and EGFR mutations were detected with DNA sequencing.The relationship between BRAF V600,EGFR mutations and the clinicopathological features were analyzed.Results BRAF V600 mutations were detected in 11 (7.5％) of the 146 specimens.BRAF V600 mutations were found morelfrequently in non-smokers (P =0.045).There were no significant differences in age,gender,histological subtype and differentiation between patients with and without BRAF V600 mutations (P ＞ 0.05).EGFR mutations were detected in 68 (46.6％) of the 146 specimens.EGFR mutations were found more frequently in women,non-smokers and adenocarcinoma (P ＜ 0.05).Four tumors with BRAF V600 mutations (three V600 and one V600D) showed concomitant EGFR mutations (two DEL and two L858R).Conclusion BRAF V600 mutations in patients with NSCLC are found more frequently in non-smokers.There are no significant differences in age,gender,histological subtype and differentiation between patients with and without BRAF mutations.关键词
肺肿瘤/BRAF V600/EGFR/突变Key words
lung neoplasms/BRAF V600/EGFR/mutation分类
医药卫生引用本文复制引用
韩义明,饶兰,丁莉,郑杰,杨婉,沈金花,邹先进..非小细胞肺癌中BRAF V600、EGFR基因突变与临床病理特征的关系[J].临床与实验病理学杂志,2017,33(4):375-378,4.基金项目
863重点项目计划资助(2011AA02A110) （2011AA02A110）
